Contraception for the transplant patient.
Patients who have had an organ transplant have a need for highly effective contraception. Intrauterine devices, depo-medroxyprogesterone acetate, and implantable etonorgestrel have the highest efficacy combined with the least chance of interaction with antirejection medication regimens. Combined hormonal contraceptives and progestin-only pills are also acceptable methods for patients who do not have other contraindications to their use. Barrier method use should be advocated for any patient who is entering a new sexual relationship and as an adjunct to other methods. Consultation with a gynecologist experienced with the provision of contraceptives to medically complicated patients is advised for all women of reproductive age who have received an organ transplant.
Division of Preventive and Ambulatory Care, Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA. cme2109@columbia.edu
Christopher M
CM
Estes
Carolyn
C
Westhoff
D017280:Condoms / Q000706:statistics & numerical data; D003267:Contraception / Q000379:methods*; D003271:Contraceptive Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007434:Intrauterine Devices / Q000706:statistics & numerical data; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects; D019737:Transplants
D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D017258:Medroxyprogesterone Acetate